Thumbnail Image
Publication

Essential information about nanotechnology in cardiology

Elendu, Chukwuka
; 
Amaechi, Dependable C.
; 
Elendu, Tochi C.
; 
Amaechi, Emmanuel C.
; 
Elendu, Ijeoma D.
; 
Omeludike, Janet C.
; 
Omeludike, Eunice K.
; 
Onubogu, Nwamaka C.
; 
Ogelle, Emmanuel C.
; 
Meduoye, Oluwatobi O. M.
... show 6 more
Advisors
Editors
Other Contributors
Affiliation
Federal University Teaching Hospital, Nigeria; Igbinedion University; Imo State University; Madonna University; University of Chester; University of Portharcourt; Abia State University; Blessed Specialist Hospital, Nigeria; Glasgow Caledonian University; St. Nicholas Hospital, Nigeria; University College hospital, Nigeria; Zaporizhzhia State Medical University
EPub Date
Publication Date
2024-12-19
Submitted Date
Collections
Chester Medical School
Show all metadata
Files
Thumbnail Image
Article - AAM
Adobe PDF, 1.45 MB
Other Titles
Abstract
Cardiology, as a medical specialty, addresses cardiovascular diseases (CVDs), a leading cause of global mortality. Nanomaterials offer transformative potential across key areas such as drug delivery, stem cell therapy, imaging, and gene delivery. Nanomaterials improve solubility, bioavailability, and targeted delivery in drug delivery, reducing systemic side effects. Examples include gas microbubbles, liposomal preparations, and paramagnetic nanoparticles, which show promise in treating atherosclerosis. Stem cell therapy benefits from nanotechnology through enhanced cell culture conditions and three-dimensional scaffolds that support cardiomyocyte growth and survival. Gold nanoparticles and PLGA-derived microparticles further improve stem cell viability. In imaging, nanomaterials enable advanced visualization techniques such as magnetic resonance imaging (MRI) with direct labeling and optical tracking via dye-conjugated nanoparticles. In gene delivery, polymeric nanocarriers like polyethyleneimine, dendrimers, and graphene-based materials offer efficient, non-viral alternatives, with magnetic nanoparticles showing promise in targeted applications. Ongoing research highlights the potential of nanomaterials to revolutionize CVD management by improving therapeutic outcomes and enabling precision medicine. These advancements position nanotechnology as a cornerstone of modern cardiology.
Citation
Elendu, C., Amaechi, D. C., Elendu, T. C., Amaechi, E. C., Elendu, I. D., Omeludike, J. C., Omeludike, E. K., Onubogu, N. C., Ogelle, E. C., Meduoye, O. O.M., Oloyede, P. O., Ezeh, C. P., Esangbedo, I. J., Adigwe, A. C., Akuma, N. M., & Okafor, S. U. (2025). Essential information about nanotechnology in cardiology. Annals of Medicine & Surgery, 87(2), 748-779. https://doi.org/10.1097/MS9.0000000000002867
Publisher
Wolters Kluwer Health
Journal
Annals of Medicine & Surgery
Research Unit
URI
http://hdl.handle.net/10034/629187
DOI
10.1097/MS9.0000000000002867
PubMed ID
PubMed Central ID
Type
Article
Language
Description
Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.
Series/Report no.
ISSN
2049-0801
EISSN
ISBN
ISMN
Gov't Doc
Test Link
Sponsors
Unfunded
Additional Links
https://journals.lww.com/annals-of-medicine-and-surgery/abstract/9900/essential_information_about_nanotechnology_in.2439.aspx